Tag: intranasal delivery
Study: Intranasal Epinephrine Absorbed Faster Than Injection and Even Better with...
Study compared absorption of epinephrine via nasal spray to that of intramuscular injection.
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
Neffy™ (formally ARS-1) was fast-tracked by the FDA in 2019 as an intranasal alternative to epinephrine auto-injectors.
Bryn Pharma Research on Epinephrine Nasal Spray Presented at ACAAI Annual...
Two studies shed light on the viability of intranasal delivery of emergency epinephrine.
Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment
Bryn’s epinephrine nasal spray provides two doses in one portable device.
Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support...
Nasal Spray Product is Disruptive Innovation for People at Risk of Anaphylaxis.
How the Opioid Crisis Could Affect the Availability of Epinephrine
Pharma is under pressure to respond which has already resulted in one company seeking bankruptcy protection.
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
Company provides a novel means of administering emergency epinephrine.
Update on Progress of Emergency Epinephrine Nasal Spray
The nasal spray would be an alternate means of delivering emergency epinephrine to the traditional auto-injector.
